Vikram Malhi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Cancer research communications

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Vikram Malhi, Priya Agarwal, Mary R Gates, Lichuan Liu, Jianshuang Wang, Tom De Bruyn, Scott Lam, Jennifer Eng-Wong, Pablo Perez-Moreno, Ya-Chi Chen, Jiajie Yu
Optimizing Early-Stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer. Cancer research communications (2023)
Ryan H Takahashi, Vikram Malhi, Bianca M Liederer, Sungjoon Cho, Yuzhong Deng, Brian Dean, James Nugteren, Edward Yost, Mohammad A Al-Sayah, Rucha Sane, Smita Kshirsagar, Shuguang Ma, Luna Musib
THE ABSOLUTE BIOAVAILABILITY AND ABSORPTION, METABOLISM, AND EXCRETION OF IPATASERTIB, A POTENT AND HIGHLY SELECTIVE AKT INHIBITOR . Drug metabolism and disposition: the biological fate of chemicals (2023)
Vikram Malhi, Nageshwar Budha, Rucha Sane, Jian Huang, Bianca Liederer, Raymond Meng, Premal Patel, Yuzhong Deng, Andres Cervantes, Josep Tabernero, Luna Musib
Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib. Cancer chemotherapy and pharmacology 88 (6) (2021)